ImmunoReagents Relocation For February 2014

Wednesday, January 8th, 2014

Dear Clients,

 

ImmunoReagents is proud to announce that we will be relocating our manufacturing operations to a new facility in February 2014.  This relocation is planned to ensure manufacturing demands are met as we continue to expand production of our research and bulk reagent product lines. We appreciate the ongoing collaborations and would like to invite you to visit with us in the coming year.

 

The address for the new facility will be: 

ImmunoReagents, Inc.

6003 Chapel Hill Road

Suite # 153

Raleigh, NC  27607

Phone:  919-831-2240

 

The relocation will be managed so that there will be minimal impact to production and orders will continue to be processed as they are received.  The production and quality systems currently used will continue to ensure that products are manufactured according to established procedures and quality standards.  A business continuity plan will be implemented and followed – ensuring a smooth transition between facilities and minimal interruption to our clients.

We will continue to update you on our progress with the move.  Thank you for your cooperation and we look forward to doing business with you in the new facility!

Please contact us with any questions regarding the ordering, shipping, or the facility relocation.

 

Kind Regards,

 

Ann Black, Ph.D.

President & CEO

ImmunoReagents, Inc.

 


ImmunoReagents, Inc. is a leading global manufacturer of quality antibodies and reagents used in pharmaceutical research, life science research and in vitro diagnostics. Product offerings include a wide range of immunochemistry reagents such as purified immunoglobulinsprimary antibodies, and secondary antibodies covering a broad spectrum of immunoglobulins from various species. ImmunoReagents also provides custom manufacturing to meet specific customer requirements while adhering to cGMP guidelines and ISO quality systems requirements. The company is located in Raleigh, North Carolina

ImmunoReagents University: